Cargando…
Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma
BACKGROUND: The introduction of rituximab into the treatment of patients with non-Hodgkin’s lymphomas has improved the overall response rate, as well as the response duration and the overall survival of patients with B-cell lymphomas. But only a few studies have addressed the question whether the be...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Versita, Warsaw
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423703/ https://www.ncbi.nlm.nih.gov/pubmed/22933921 http://dx.doi.org/10.2478/v10019-010-0044-6 |